Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALAB vs MRNA✓SelectedUSD · MRNAALAB vs MRNA performance historyLatest closeAs of-2.62%11/13
Stock and ETF performance explorer

ALAB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.3%
MRNA return
+250.1%
Excess return
-281.4%
Maximum drawdown
-54.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.6%-3.4%+0.8%-2.6%
7D+16.3%-12.1%+28.4%+16.3%
30D-26.1%-1.3%-24.8%-26.0%
3M-31.3%+250.9%-282.2%-27.2%
All-31.3%+250.1%-281.4%-27.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3mo analysis · Full analysis span regression · Available span rolling